Targeting the TREM1-positive myeloid microenvironment in glioblastoma

BACKGROUND: Tumor cellular and molecular heterogeneity is a hallmark of glioblastoma and underlies treatment resistance and recurrence. This manuscript investigated the myeloid-derived microenvironment as a driver of glioblastoma heterogeneity and provided a pharmacological pathway for its suppressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippova, Natalia, Grimes, Jeffrey M, Leavenworth, Jianmei W, Namkoong, David, Yang, Xiuhua, King, Peter H, Crowley, Michael, Crossman, David K, Nabors, L Burt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555298/
https://www.ncbi.nlm.nih.gov/pubmed/36249290
http://dx.doi.org/10.1093/noajnl/vdac149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555298/
https://www.ncbi.nlm.nih.gov/pubmed/36249290
http://dx.doi.org/10.1093/noajnl/vdac149

Ejemplares similares